Intellia Therapeutics (NTLA) Return on Equity [ROE] (2016 - 2026)
Intellia Therapeutics (NTLA) recorded Return on Equity [ROE] of -59.21% in Q2 2026, up 1404.54 percentage points from -1463.76% a year earlier and up 1.90 percentage points from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2025, Intellia Therapeutics reported Return on Equity [ROE] of -53.36%, down 2.75 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for five straight years, with a five-year change of -19.68 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -50.62% in FY2024 (-9.89 pp), -40.73% in FY2023 (-1.21 pp), -39.51% in FY2022 (-5.50 pp) and -34.02% in FY2021 (-0.33 pp).
- Quarterly Return on Equity [ROE] has ranged from -2685.66% in Q3 2025 to -24.83% in Q4 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] rose in 1 of the last eight quarters, with an average year-over-year change of -335.76 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 1404.54 percentage points in Q2 2026, against a drop of 2635.18 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -61.12% (Q1 2026), -58.01% (Q4 2025) and -2685.66% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Intellia Therapeutics | 1.57 Bn | -171.10 Mn | - | -64.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -64.09% |
| Jun 30, 2026 | -59.56% |
| Mar 31, 2026 | -61.27% |
| Dec 31, 2025 | -58.07% |
| Sep 30, 2025 | -61.23% |
| Jun 30, 2025 | -63.99% |
| Mar 31, 2025 | -63.43% |
| Dec 31, 2024 | -56.50% |
| Sep 30, 2024 | -53.53% |
| Jun 30, 2024 | -50.64% |
| Mar 31, 2024 | -46.58% |
| Dec 31, 2023 | -45.60% |
| Sep 30, 2023 | -42.63% |
| Jun 30, 2023 | -39.01% |
| Mar 31, 2023 | -35.04% |
| Dec 31, 2022 | -46.49% |
| Sep 30, 2022 | -52.91% |
| Jun 30, 2022 | -44.70% |
| Mar 31, 2022 | -37.77% |
| Dec 31, 2021 | -25.20% |
API Access
Intellia Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();